Episode 5 – On Demand
The FAST™ System has the Potential to Expedite ID & AST for Bloodborne Pathogens from Positive Blood Cultures
David Pride, MD, PhD, Infectious Disease Specialist, UC San Diego Health
Episode 4 – On Demand
Impact of reducing time to results in septic patient management
Dr. David Haake, Chief Medical Officer, Qvella
Episode 2 – On Demand
Reduce time from PBC to actionable results by generating a Liquid Colony™
Herbert Torfs, PhD, V.P. of Business Development EMEA, Qvella and Professor Alexia Verroken, MD, PhD, Clinical Microbiologist, Saint-Luc University Hospital
Evaluation of a Novel Sample Preparation Method for Rapid Antimicrobial Resistance Testing Directly from Positive Blood Cultures.
Comparison of a Novel Sample Preparation Method for Positive Blood Cultures vs. Standard of Care Overnight Sub-Culture: 0.5 McFarland Cell Concentrations and Antimicrobial Susceptibility Test Results.
Analysis of the FAST-Prep™ PBC System for expedited identification and susceptibilities of bloodborne pathogens.
Performances of the FAST-Prep™ PBC System enabling speeded-up positive blood culture ID/AST results using Bruker MALDI-TOF MS< BD Phoenix and disk diffusion.
Evaluation of the FAST-Prep™ PBC System: an automated and rapid system for isolating microbial cells from positive blood culture.
Evaluation of the FAST-Prep™ PBC System (Qvella) for accelerated species identification and antimicrobial susceptibility testing from positive blood culture bottles using the Bruker MALDI and bioMerieux Vitek 2.
The FAST™ System is under development. The user is responsible for validating the FAST™ System in combination with diagnostic procedures used in their laboratory and in accordance with applicable regulations.